Respiratory system toxicity induced by immune checkpoint inhibitors: A real-world study based on the FDA adverse event reporting system database

BACKGROUND: Immune checkpoint inhibitors (ICIs), the treatment of multiple cancer types, can be associated with respiratory system adverse events (AEs). The aim of this study is to quantify the association of respiratory system AEs and ICIs and to characterize the profiles of ICI-related respiratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Chanjuan, Deng, Lei, Wang, Wenqing, Ren, Xiayang, Wang, Yanfeng, Cui, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437516/
https://www.ncbi.nlm.nih.gov/pubmed/36059699
http://dx.doi.org/10.3389/fonc.2022.941079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437516/
https://www.ncbi.nlm.nih.gov/pubmed/36059699
http://dx.doi.org/10.3389/fonc.2022.941079

Ejemplares similares